All Work

Rich Duprey

Amazon Is Ready to Take on StarLink in Space-Based Broadband

Starlink has turned space-based internet into a major business for SpaceX. What began as prototypes around 2019 has grown into a constellation of more than 11,500 launched satellites, with over 10,000 actively in orbit…

Rich Duprey · 5 months ago

Beat the S&P 500 Without the Magnificent 7 Risk

For decades, plain-vanilla index investing was the easiest way to build wealth without losing sleep. The S&P 500 had delivered roughly 10% average annual returns over the long haul, so simply buying a low-cost…

Rich Duprey · 5 months ago

Was Warren Buffett’s Coca-Cola Investment a Mistake?

Warren Buffett long favored PepsiCo (NASDAQ:PEP | PEP Price Prediction) in Berkshire Hathaway’s (NYSE:BRK-A)(NYSE:BRK-B) portfolio, viewing the snack-and-beverage powerhouse as a reliable compounder. That changed dramatically in 1988, when Buffett sold down his Pepsi…

Rich Duprey · 6 months ago

Here’s How Ondas Can Repeat Last Year’s 281% Gain in 2026

Ondas Holdings (NASDAQ:ONDS) nearly quadrupled in value during calendar 2025, delivering a staggering 281% gain. Yet the real drama lies in the trailing 12-month return: the stock has soared an eye-popping 1,358%. That makes…

Rich Duprey · 6 months ago

Super Micro Risks S&P 500 Removal. Here’s the Stock to Replace It

Super Micro Computer (NASDAQ:SMCI | SMCI Price Prediction) shares cratered roughly 33% yesterday after U.S. prosecutors charged the company’s co-founder, Yih-Shyan “Wally” Liaw, along with sales manager Ruei-Tsang Chang and contractor Ting-Wei Sun, in…

Rich Duprey · 6 months ago

CrowdStrike Hitches Ride on Nebius Rocket. Is It Time to Buy?

CrowdStrike (NASDAQ:CRWD | CRWD Price Prediction) ranks among the handful of software stocks that JPMorgan highlighted as resilient to the AI threat sweeping the sector. In February, the bank noted that high switching costs…

Rich Duprey · 6 months ago

Eli Lilly Just Opened the Door to Even Greater GLP-1 Growth

Eli Lilly’s (NYSE:LLY | LLY Price Prediction) GLP-1 therapy Zepbound has become the biggest weight loss drug since its introduction, outpacing Novo Nordisk’s (NYSE:NVO) Wegovy in both sales momentum and patient preference. But the…

Rich Duprey · 6 months ago

Nebius Just Cemented Its Lead as the Premier Neocloud Stock to Buy

Investors in Nebius Group (NASDAQ:NBIS | NBIS Price Prediction) endured a punishing stretch last fall when aggressive capital-expenditure plans sparked deep concerns about cash burn and execution risk. The stock that had climbed to…

Rich Duprey · 6 months ago